- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $317.92M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $335.49M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $326.49M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $198.7M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $195.49M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $763.31M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $775.28M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $355.56M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $351.48M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.28B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.29B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $187.92M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $274.5M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 64.5M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $5.15M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $17.71M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.33 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.33 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $63.07M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $19.38M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$21.22M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $7.69M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $144.88M |
| Revenue | Q1 2025 · Mar 31, 2024 | $237M |